Glytec

Glytec is a leader in personalized digital therapeutics, delivering advanced solutions for both inpatient and outpatient insulin management. The company offers patented, FDA-cleared software-as-a-medical-device (SaMD) designed to enhance patient safety and improve health outcomes for people living with diabetes. By making insulin therapy more precise and effective, Glytec helps address the needs of millions of patients who struggle to meet their treatment goals.Through the integration of evidence-based clinical decision support technology and specialized clinical services, Glytec optimizes basal and bolus insulin therapies across hospital and home care settings. This comprehensive approach supports better glycemic control, reduces the risk of hypoglycemia and related complications, and helps lower avoidable emergency department visits, hospitalizations, readmissions, and medication waste.